Do you ever receive questions about the research behind medical interventions for individuals with ASD?
The Agency for Healthcare and Research Quarterly (AHRQ) recently published an updated report on the effectiveness of medical interventions for children with ASD. The report was focused on 6 key questions.
- Among children ages 2-12 with ASD, what is the comparative effectiveness (benefits and harms) of medical treatments?
- Among children ages 2-12 with ASD, what are the modifiers of outcome for different medical treatments?
- What is the time to effect of medical interventions?
- What is the evidence that effects measured at the end of the treatment phase predict long-term functional outcomes of medical interventions?
- Is the effectiveness of medical interventions maintained across environments or contexts (e.g., people, places, materials)?
- What evidence supports specific components of treatment with medical interventions as driving outcomes, either within a single treatment or across treatments?
The Executive Summary (14 pages) provides a report of the key findings.
The Full Report (713 pages) is also available, and provides a detailed analysis of each article the investigators reviewed.
I hope you find these resources informative. I’m looking forward to connecting with many of you on Friday for CASP’s Virtual Round Table on CPT Codes!
Executive Director, Council of Autism Service Providers